Detalles de la búsqueda
1.
Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication.
Immunity;
55(6): 1032-1050.e14, 2022 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704993
2.
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.
Mol Cancer;
23(1): 37, 2024 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38374062
3.
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide.
Mol Cancer;
23(1): 38, 2024 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38378555
4.
Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers.
Lab Invest;
103(5): 100063, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36801637
5.
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Lancet Oncol;
21(3): 446-455, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32078813
6.
Aryl hydrocarbon receptor control of a disease tolerance defence pathway.
Nature;
511(7508): 184-90, 2014 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24930766
7.
In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.
Neurobiol Dis;
103: 101-112, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28411117
8.
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study.
Biomark Res;
12(1): 3, 2024 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185642
9.
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res;
30(4): 779-785, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048058
10.
Antitumor Effects of PRMT5 Inhibition in Sarcomas.
Cancer Res Commun;
3(11): 2211-2220, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861293
11.
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer.
Clin Cancer Res;
29(23): 4883-4893, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37756581
12.
Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone.
Am J Physiol Regul Integr Comp Physiol;
303(2): R135-43, 2012 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22592557
13.
Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives.
Front Immunol;
13: 807271, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35173722
14.
Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease.
Int J Tryptophan Res;
15: 11786469221118657, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36004319
15.
Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer.
Exp Hematol Oncol;
11(1): 104, 2022 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36474303
16.
Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma.
J Hematol Oncol;
15(1): 149, 2022 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36271420
17.
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study.
J Hematol Oncol;
15(1): 157, 2022 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36303228
18.
Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1/PD-L1 antibodies.
J Immunother Cancer;
10(5)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35618288
19.
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial.
Eur J Cancer;
162: 161-169, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34998048
20.
Trabectedin plus Durvalumab in Patients with Advanced Pretreated Soft Tissue Sarcoma and Ovarian Carcinoma (TRAMUNE): An Open-Label, Multicenter Phase Ib Study.
Clin Cancer Res;
28(9): 1765-1772, 2022 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965951